The Companies and Markets show: Haleon listing, the business of psychedelics, and a European gas crisis

On this week's show, we get the breakdown on GSK spinoff Haleon which is set to list next week.Then Arthur Sants takes a fascinating dive into the business of psychedelic drugs, and whether they can be the future of depression and anxiety treatment.Finally, the panel look into the potential European gas crisis, with the threat of Russian pipelines being turned off hanging over the continent.Dan Jones host Alex Newman, Alex Hamer, Mark Robinson and Arthur Sants.Timestamps:00:00 - Intro01:00 - News roundup02:49 - GSK spinoff Haleon listing previewed13:24 - Can psychedelics be the future of anxiety treatment?23:16 - A looming European gas crisis? Hosted on Acast. See acast.com/privacy for more information.

Om Podcasten

Looking for help with your Isa or pension? Or just plain confused by the stock market? Each week, Investors' Chronicle picks apart the latest news for companies, markets and funds, and brings you fresh investment ideas. Subscribe for these, along with interviews with professional investors and special in-depth discussions on big market themes. Hosted on Acast. See acast.com/privacy for more information.